1. Home
  2. AMPL vs PHAT Comparison

AMPL vs PHAT Comparison

Compare AMPL & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$6.99

Market Cap

914.7M

Sector

Technology

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$13.19

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
PHAT
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
914.7M
894.0M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
AMPL
PHAT
Price
$6.99
$13.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
6
Target Price
$13.42
$19.83
AVG Volume (30 Days)
1.6M
958.0K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
42.72
EPS
N/A
N/A
Revenue
$343,214,000.00
$175,110,000.00
Revenue This Year
$17.43
$93.04
Revenue Next Year
$14.16
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
14.68
216.93
52 Week Low
$5.51
$2.21
52 Week High
$14.27
$18.31

Technical Indicators

Market Signals
Indicator
AMPL
PHAT
Relative Strength Index (RSI) 53.72 68.54
Support Level $6.18 $13.02
Resistance Level $7.89 $14.37
Average True Range (ATR) 0.39 0.59
MACD 0.09 0.23
Stochastic Oscillator 92.28 99.17

Price Performance

Historical Comparison
AMPL
PHAT

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: